| Judith Bressler, MD | |
|
120 Spalding Dr Ste 309, Naperville, IL 60540-6521 | |
| (630) 432-6890 | |
| Not Available |
| Full Name | Judith Bressler |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 120 Spalding Dr Ste 309, Naperville, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194726547 | NPI | - | NPPES |
| 036076544 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036076544 (Illinois) | Primary |
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Human Genome Sciences, Inc. today announced the closing of its public offering of 17,825,000 newly issued shares of its common stock at a price to the public of $26.75 per share, which includes 2,325,000 shares sold upon exercise by the underwriters of their option to purchase additional shares. The net proceeds to the Company from the offering are approximately $456.3 million, after deducting the underwriting discount and estimated offering expenses.
The study titled, "State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter," was published in the journal Drug and Alcohol Dependence.
Researchers from the Universities of Edinburgh and Aberdeen and St George's Medical School in London say one in five children and adults in Britain suffer from allergies, with annual health services treatment bill running at £1billion. They call for more allergy specialists to meet the increased demand.
Digitalization is changing the healthcare system: Digital technologies are opening up new opportunities in the development of innovative medications and the healthcare solutions of tomorrow.
ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judith Bressler, MD 1860 Paysphere Cir, Chicago, IL 60674-0018 Ph: (630) 469-9200 | Judith Bressler, MD 120 Spalding Dr Ste 309, Naperville, IL 60540-6521 Ph: (630) 432-6890 |
News Archive
Human Genome Sciences, Inc. today announced the closing of its public offering of 17,825,000 newly issued shares of its common stock at a price to the public of $26.75 per share, which includes 2,325,000 shares sold upon exercise by the underwriters of their option to purchase additional shares. The net proceeds to the Company from the offering are approximately $456.3 million, after deducting the underwriting discount and estimated offering expenses.
The study titled, "State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter," was published in the journal Drug and Alcohol Dependence.
Researchers from the Universities of Edinburgh and Aberdeen and St George's Medical School in London say one in five children and adults in Britain suffer from allergies, with annual health services treatment bill running at £1billion. They call for more allergy specialists to meet the increased demand.
Digitalization is changing the healthcare system: Digital technologies are opening up new opportunities in the development of innovative medications and the healthcare solutions of tomorrow.
ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.
› Verified 3 days ago
Dr. Yuri Zermeno, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Spalding Dr Ste 406, Naperville, IL 60540 Phone: 630-961-9485 Fax: 630-961-9578 | |
Dr. Michael T Feingold, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 640 S Washington St, Ste 220, Naperville, IL 60540 Phone: 630-428-1500 Fax: 630-428-3544 | |
Dr. Elena Pirozhnik, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 W Martin Ave # 100, Naperville, IL 60540 Phone: 630-369-7700 Fax: 630-369-7705 | |
Dr. Melissa May Deer Pelletier, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 636 Raymond Dr Ste 303, Naperville, IL 60563 Phone: 630-653-4240 Fax: 630-315-1505 | |
Dr. Andrew K. Badowski, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10 W Martin Ave # 100, Naperville, IL 60540 Phone: 630-369-7700 Fax: 630-369-7705 | |
Dr. Charles Edward Miller, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 Osler Drive, Suite 100, Naperville, IL 60540 Phone: 630-428-2229 Fax: 630-428-0336 | |
Meghan M Flannery, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 720 Brom Ct, S-104, Naperville, IL 60540 Phone: 630-717-9977 Fax: 630-717-6267 |